ACM
OFIX icon

Acrisure Capital Management’s Orthofix Medical OFIX Stock Holding History

Acrisure Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,001
Closed -$201K – 173
2023
Q1 		$201K Buy
+12,001
New +$235K 0.2% 231

Other funds holding OFIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acrisure Capital Management's OFIX Position: Q2 2023 in Review

Acrisure Capital Management sold out of Orthofix Medical (OFIX) in Q2 2023, closing a stake of 12,001 shares — an estimated $201K sold.

Acrisure Capital Management first reported a position in OFIX in Q1 2023 and held it in 1 quarter. The position peaked at $201K in Q1 2023. 150 funds tracked by Wall St. Rank hold OFIX as of Q2 2023.

  • Acrisure Capital Management reported no remaining Orthofix Medical position as of Q2 2023 after selling out during the quarter.
  • Acrisure Capital Management sold 12,001 Orthofix Medical shares in Q2 2023, an estimated $201K.
  • Acrisure Capital Management first reported a position in Orthofix Medical in Q1 2023 and held it in 1 quarter.
  • Acrisure Capital Management's Orthofix Medical position peaked at $201K in Q1 2023.
  • 150 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2023.

Based on Acrisure Capital Management's 13F filing for Q2 2023.